| For: | Cervello M, Foderà D, Florena AM, Soresi M, Tripodo C, D’Alessandro N, Montalto G. Correlation between expression of cyclooxygenase-2 and the presence of inflammatory cells in human primary hepatocellular carcinoma: Possible role in tumor promotion and angiogenesis. World J Gastroenterol 2005; 11(30): 4638-4643 [PMID: 16094702 DOI: 10.3748/wjg.v11.i30.4638] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i30/4638.htm |
| Number | Citing Articles |
| 1 |
Cosmo Damiano Gadaleta, Rosario Sacco, Angelo Vacca, Caroline Oakley, Ines Abbate, Annamaria Laterza, Ilaria Marech, Michele Ammendola, Girolamo Ranieri. Vascular endothelial growth factor and tryptase changes after chemoembolization in hepatocarcinoma patients. World Journal of Gastroenterology 2015; 21(19): 6018-6025 doi: 10.3748/wjg.v21.i19.6018
|
| 2 |
Nabil M. Abdel-Hamid, Amer Hasan Abdullah. Serum histamine and acetylcholine variations as new noninvasive biochemical markers in staging of experimental hepatocellular carcinoma. Clinical and Experimental Medicine 2019; 19(1) doi: 10.1007/s10238-018-0537-y
|
| 3 |
Xiao-Dong Zhu, Ju-Bo Zhang, Peng-Yuan Zhuang, Hong-Guang Zhu, Wei Zhang, Yu-Quan Xiong, Wei-Zhong Wu, Lu Wang, Zhao-You Tang, Hui-Chuan Sun. High Expression of Macrophage Colony-Stimulating Factor in Peritumoral Liver Tissue Is Associated With Poor Survival After Curative Resection of Hepatocellular Carcinoma. Journal of Clinical Oncology 2008; 26(16) doi: 10.1200/JCO.2007.15.6521
|
| 4 |
F. Millanta, G. Andreani, G. Rocchigiani, D. Lorenzi, A. Poli. Correlation Between Cyclo-oxygenase-2 and Vascular Endothelial Growth Factor Expression in Canine and Feline Squamous Cell Carcinomas. Journal of Comparative Pathology 2016; 154(4) doi: 10.1016/j.jcpa.2016.02.005
|
| 5 |
D. Hattis, M. Chu, N. Rahmioglu, R. Goble, P. Verma, K. Hartman, M. Kozlak. A Preliminary Operational Classification System for Nonmutagenic Modes of Action for Carcinogenesis. Critical Reviews in Toxicology 2009; 39(2) doi: 10.1080/10408440802307467
|
| 6 |
Melchiorre Cervello, Giuseppe Montalto. Cyclooxygenases in hepatocellular carcinoma. World Journal of Gastroenterology 2006; 12(32): 5113-5121 doi: 10.3748/wjg.v12.i32.5113
|
| 7 |
Patricia de la Cruz-Ojeda, Rocío Flores-Campos, Sandra Dios-Barbeito, Elena Navarro-Villarán, Jordi Muntané. Role of Nitric Oxide in Gene Expression Regulation during Cancer: Epigenetic Modifications and Non-Coding RNAs. International Journal of Molecular Sciences 2021; 22(12) doi: 10.3390/ijms22126264
|
| 8 |
Chao Sun, Naohiro Hosomura, Masato Tsuchiya, Yuuki Nakata, Yoshihiro Akazawa, Kazuyoshi Hirayama, Michio Hara, Shinji Furuya, Hideki Fujii, Hiroshi Kono. Macrophage colony-stimulating factor expressed in non-cancer tissues provides predictive powers for recurrence in hepatocellular carcinoma. World Journal of Gastroenterology 2016; 22(39): 8779-8789 doi: 10.3748/wjg.v22.i39.8779
|
| 9 |
Heather Francis, Cynthia J. Meininger. A review of mast cells and liver disease: What have we learned?. Digestive and Liver Disease 2010; 42(8) doi: 10.1016/j.dld.2010.02.016
|
| 10 |
Magda SA Abdeltawab, Iman R. Abdel-Shafi, Basma Emad Aboulhoda, Amal M. Mahfoz, Alshaimaa MR Hamed. The neuroprotective potential of curcumin on T. Spiralis infected mice. BMC Complementary Medicine and Therapies 2024; 24(1) doi: 10.1186/s12906-024-04399-0
|
| 11 |
Jessica L. Petrick, Vikrant V. Sahasrabuddhe, Andrew T. Chan, Michael C. Alavanja, Laura E. Beane-Freeman, Julie E. Buring, Jie Chen, Dawn Q. Chong, Neal D. Freedman, Charles S. Fuchs, John Michael Gaziano, Edward Giovannucci, Barry I. Graubard, Albert R. Hollenbeck, Lifang Hou, Eric J. Jacobs, Lindsay Y. King, Jill Koshiol, I-Min Lee, Martha S. Linet, Julie R. Palmer, Mark P. Purdue, Lynn Rosenberg, Catherine Schairer, Howard D. Sesso, Alice J. Sigurdson, Jean Wactawski-Wende, Anne Zeleniuch-Jacquotte, Peter T. Campbell, Katherine A. McGlynn. NSAID Use and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: The Liver Cancer Pooling Project. Cancer Prevention Research 2015; 8(12) doi: 10.1158/1940-6207.CAPR-15-0126
|
| 12 |
Laetitia Fartoux, Thomas Decaens. Contribution of biomarkers and imaging in the management of hepatocellular carcinoma. Clinics and Research in Hepatology and Gastroenterology 2011; 35 doi: 10.1016/S2210-7401(11)70004-3
|
| 13 |
A Fernández-Alvarez, C Llorente-Izquierdo, R Mayoral, N Agra, L Boscá, M Casado, P Martín-Sanz. Evaluation of epigenetic modulation of cyclooxygenase-2 as a prognostic marker for hepatocellular carcinoma. Oncogenesis 2012; 1(7) doi: 10.1038/oncsis.2012.23
|
| 14 |
Magda Hamzawy, Laila Elsaid, Asmaa Shams, Laila Rashid, Soheir Mahfouz, Nivin Sharawy. Study of the Effects of Cyclooxygenase-2 Inhibitor on the Promotion of Hepatic Tumorigenesis in Rats Fed a High Fat Diet. Journal of Clinical and Experimental Hepatology 2015; 5(1) doi: 10.1016/j.jceh.2014.12.010
|
| 15 |
Lydia Giannitrapani, Sabrina Ingrao, Maurizio Soresi, Ada Maria Florena, Emanuele La Spada, Luigi Sandonato, Natale D'Alessandro, Melchiorre Cervello, Giuseppe Montalto. Cyclooxygenase‐2 Expression in Chronic Liver Diseases and Hepatocellular Carcinoma. Annals of the New York Academy of Sciences 2009; 1155(1) doi: 10.1111/j.1749-6632.2009.03698.x
|
| 16 |
Chun-Chieh Yeh, Jaw-Town Lin, Long-Bin Jeng, Hsiu J. Ho, Horng-Ren Yang, Ming-Shiang Wu, Ken N. Kuo, Chun-Ying Wu. Nonsteroidal Anti-inflammatory Drugs Are Associated With Reduced Risk of Early Hepatocellular Carcinoma Recurrence After Curative Liver Resection. Annals of Surgery 2015; 261(3) doi: 10.1097/SLA.0000000000000746
|
| 17 |
Fei Wang, Hongxia Ma, Zhaoguo Liu, Wei Huang, Xiaojing Xu, Xuemei Zhang. α-Mangostin inhibits DMBA/TPA-induced skin cancer through inhibiting inflammation and promoting autophagy and apoptosis by regulating PI3K/Akt/mTOR signaling pathway in mice. Biomedicine & Pharmacotherapy 2017; 92 doi: 10.1016/j.biopha.2017.05.129
|
| 18 |
Jeng-Wei Tjiu, Jau-Shiuh Chen, Chia-Tung Shun, Sung-Jan Lin, Yi-Hua Liao, Chia-Yu Chu, Tsen-Fang Tsai, Hsien-Ching Chiu, Yang-Shia Dai, Hiroyasu Inoue, Pan-Chyr Yang, Min-Liang Kuo, Shiou-Hwa Jee. Tumor-Associated Macrophage-Induced Invasion and Angiogenesis of Human Basal Cell Carcinoma Cells by Cyclooxygenase-2 Induction. Journal of Investigative Dermatology 2009; 129(4) doi: 10.1038/jid.2008.310
|
| 19 |
Meng Lu, Jiao Wu, Feng He, Xi-Long Wang, Can Li, Zhi-Nan Chen, Huijie Bian. Cell expression patterns of CD147 in N-diethylnitrosamine/phenobarbital-induced mouse hepatocellular carcinoma. Journal of Molecular Histology 2015; 46(1) doi: 10.1007/s10735-014-9602-3
|
| 20 |
Eman A. Bayomi, Ahmed B. Barakat, Maha A. El-Bassuoni, Randa M. Talaat, Mervat M. El-Deftar, Sabrin A. Abdel Wahab, Ayman M. Metwally. Cyclooxygenase-2 expression is associated with elevated aspartate aminotransferase level in hepatocellular carcinoma. Journal of Cancer Research and Therapeutics 2015; 11(4) doi: 10.4103/0973-1482.147692
|
| 21 |
Chien-Yi Tung, Chih-Hung Jen, Ming-Ta Hsu, Hsei-Wei Wang, Chi-Hung Lin. A novel regulatory event-based gene set analysis method for exploring global functional changes in heterogeneous genomic data sets. BMC Genomics 2009; 10(1) doi: 10.1186/1471-2164-10-26
|
| 22 |
Chun-Xia Ren, Rui-Xue Leng, Yin-Guang Fan, Hai-Feng Pan, Bao-Zhu Li, Chang-Hao Wu, Qiang Wu, Na-Na Wang, Qi-Ru Xiong, Xiao-Ping Geng, Dong-Qing Ye. Intratumoral and peritumoral expression of CD68 and CD206 in hepatocellular carcinoma and their prognostic value. Oncology Reports 2017; 38(2) doi: 10.3892/or.2017.5738
|
| 23 |
M. Bardagí, D. Fondevila, L. Ferrer. Immunohistochemical Detection of COX-2 in Feline and Canine Actinic Keratoses and Cutaneous Squamous Cell Carcinoma. Journal of Comparative Pathology 2012; 146(1) doi: 10.1016/j.jcpa.2011.03.012
|
| 24 |
Li-Jie Wang, Li Bai, Dan Su, Ting Zhang, Zhi-Yuan Mao. Proinflammatory conditions promote hepatocellular carcinoma onset and progression via activation of Wnt and EGFR signaling pathways. Molecular and Cellular Biochemistry 2013; 381(1-2) doi: 10.1007/s11010-013-1700-0
|
| 25 |
Jason Foster, Jennifer Black, Charles LeVea, Thaer Khoury, Boris Kuvshinoff, Miland Javle, John F. Gibbs. COX-2 Expression in Hepatocellular Carcinoma is an Initiation Event; While EGF Receptor Expression with Downstream Pathway Activation is a Prognostic Predictor of Survival. Annals of Surgical Oncology 2007; 14(2) doi: 10.1245/s10434-006-9123-8
|
| 26 |
Mario M. Alba, Brandon Ebright, Brittney Hua, Ielyzaveta Slarve, Yiren Zhou, Yunyi Jia, Stan G. Louie, Bangyan L. Stiles. Eicosanoids and other oxylipins in liver injury, inflammation and liver cancer development. Frontiers in Physiology 2023; 14 doi: 10.3389/fphys.2023.1098467
|
| 27 |
Jun Yu, Joseph JY Sung. Cyclooxygenase‐2 (COX‐2): Does it matter in patients with HCV‐related liver cirrhosis?. Journal of Gastroenterology and Hepatology 2007; 22(8) doi: 10.1111/j.1440-1746.2007.04998.x
|
| 28 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; doi: 10.1007/978-3-319-26956-6_5
|
| 29 |
VERONICA GOFFREDO, COSMO DAMIANO GADALETA, ANNAMARIA LATERZA, ANGELO VACCA, GIROLAMO RANIERI. Tryptase serum levels in patients suffering from hepatocellular carcinoma undergoing intra-arterial chemoembolization: Possible predictive role of response to treatment. Molecular and Clinical Oncology 2013; 1(2) doi: 10.3892/mco.2013.59
|
| 30 |
Xiaoqiang Gao, Shi Zuo. Immune landscape and immunotherapy of hepatocellular carcinoma: focus on innate and adaptive immune cells. Clinical and Experimental Medicine 2023; 23(6) doi: 10.1007/s10238-023-01015-2
|
| 31 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; doi: 10.1007/978-3-319-26587-2_5-1
|
| 32 |
Lydia Giannitrapani, Maurizio Soresi, Sabrina Ingrao, Emanuele La Spada, Onofrio Vuturo, Ada Maria Florena, Melchiorre Cervello, Giuseppe Montalto. Response to antiviral therapy and hepatic expression of cyclooxygenases in chronic hepatitis C. European Journal of Gastroenterology & Hepatology 2007; 19(11) doi: 10.1097/MEG.0b013e3282f01e91
|
| 33 |
Vikrant V. Sahasrabuddhe, Munira Z. Gunja, Barry I. Graubard, Britton Trabert, Lauren M. Schwartz, Yikyung Park, Albert R. Hollenbeck, Neal D. Freedman, Katherine A. McGlynn. Nonsteroidal Anti-inflammatory Drug Use, Chronic Liver Disease, and Hepatocellular Carcinoma. JNCI: Journal of the National Cancer Institute 2012; 104(23) doi: 10.1093/jnci/djs452
|
| 34 |
Melchiorre Cervello, Dimcho Bachvarov, Nadia Lampiasi, Antonella Cusimano, Antonina Azzolina, James A. McCubrey, Giuseppe Montalto, Manlio Vinciguerra. Novel Combination of Sorafenib and Celecoxib Provides Synergistic Anti-Proliferative and Pro-Apoptotic Effects in Human Liver Cancer Cells. PLoS ONE 2013; 8(6) doi: 10.1371/journal.pone.0065569
|
| 35 |
Katherine A. McGlynn, Jessica L. Petrick, W. Thomas London. Global Epidemiology of Hepatocellular Carcinoma. Clinics in Liver Disease 2015; 19(2) doi: 10.1016/j.cld.2015.01.001
|
| 36 |
Hugo Gregório, Teresa P. Raposo, Felisbina L. Queiroga, Justina Prada, Isabel Pires. Investigating associations of cyclooxygenase-2 expression with angiogenesis, proliferation, macrophage and T-lymphocyte infiltration in canine melanocytic tumours. Melanoma Research 2016; 26(4) doi: 10.1097/CMR.0000000000000262
|
| 37 |
A. M. R. Hamed, I. R. Abdel-Shafi, M. D. A. Elsayed, A. M. Mahfoz, S. E. Tawfeek, M. S. A. Abdeltawab. Investigation of the effect of curcumin on oxidative stress, local inflammatory response, COX-2 expression, and microvessel density in Trichinella spiralis induced enteritis, myositis and myocarditis in mice. Helminthologia 2022; 59(1) doi: 10.2478/helm-2022-0002
|
| 38 |
Ashwini Arvind, Tracey G. Simon. Controversies in Hepatocellular Carcinoma. 2025; doi: 10.1007/978-3-031-90225-3_6
|
| 39 |
Pei-Chang Lee, Chiu-Mei Yeh, Yu-Wen Hu, Chun-Chia Chen, Chia-Jen Liu, Chien-Wei Su, Teh-Ia Huo, Yi-Hsiang Huang, Yee Chao, Tzeng-Ji Chen, Han-Chieh Lin, Jaw-Ching Wu. Antiplatelet Therapy is Associated with a Better Prognosis for Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma after Liver Resection. Annals of Surgical Oncology 2016; 23(S5) doi: 10.1245/s10434-016-5520-9
|
| 40 |
Xueyan Jiang, Yaodong Ping, Yuan Chen, Benben Zhu, Rong Fu, Yiwei Hao, Lei Fan. A study on construction of a prognosis model for liver cancer based on analgesic targets and screening therapeutic drugs. Genes & Genomics 2024; 46(7) doi: 10.1007/s13258-024-01515-9
|
| 41 |
Daria Capece, Mariafausta Fischietti, Daniela Verzella, Agata Gaggiano, Germana Cicciarelli, Alessandra Tessitore, Francesca Zazzeroni, Edoardo Alesse. The Inflammatory Microenvironment in Hepatocellular Carcinoma: A Pivotal Role for Tumor-Associated Macrophages. BioMed Research International 2013; 2013 doi: 10.1155/2013/187204
|
| 42 |
Osmar Damasceno Ribeiro, Nathalie Henriques Silva Canedo, Vera Lucia Pannain. Immunohistochemical angiogenic biomarkers in hepatocellular carcinoma and cirrhosis: correlation with pathological features. Clinics 2016; 71(11) doi: 10.6061/clinics/2016(11)04
|
| 43 |
Melchiorre Cervello, James A. McCubrey, Antonella Cusimano, Nadia Lampiasi, Antonina Azzolina, Giuseppe Montalto. Targeted therapy for hepatocellular carcinoma: novel agents on the horizon. Oncotarget 2012; 3(3) doi: 10.18632/oncotarget.466
|
| 44 |
Mehmet ßahin, Emel ßahin, Saadet Gümüşlü. Cyclooxygenase-2 in Cancer and Angiogenesis. Angiology 2009; 60(2) doi: 10.1177/0003319708318378
|
| 45 |
SK Hasan, R Khan, N Ali, AQ Khan, MU Rehman, M Tahir, A Lateef, S Nafees, SJ Mehdi, S Rashid, A Shahid, S Sultana. 18-β Glycyrrhetinic acid alleviates 2-acetylaminofluorene-induced hepatotoxicity in Wistar rats. Human & Experimental Toxicology 2015; 34(6) doi: 10.1177/0960327114554045
|
| 46 |
Snehal S. Patel, Richa Tripathi, Vishal K. Chavda, Jignasa K. Savjani. Anticancer Potential of Mefenamic Acid Derivatives with Platelet-Derived Growth Factor Inhibitory Property. Anti-Cancer Agents in Medicinal Chemistry 2020; 20(8) doi: 10.2174/1871520620666200415100614
|